Chengdu Bright Eye Hospital Stock Hits Day High with 13.94% Surge

Chengdu Bright Eye Hospital Co., Ltd. has experienced a significant surge in its stock performance, gaining 13.94% on August 10, 2026. The stock reached an intraday high of CNY 40.02, marking a notable achievement for the small-cap hospital operator. In terms of performance metrics, Chengdu Bright Eye Hospital has shown a 17.14% increase over the past week and a remarkable 27.52% rise over the last month, significantly outperforming the China Shanghai Composite, which recorded gains of 4.12% and a decline of 0.74%, respectively. However, the stock has faced challenges over the past year, with a decline of 9.2%, contrasting with the benchmark's positive performance of 9.12%. Financially, the company reported its highest net sales at CNY 820.35 million, alongside a notable improvement in its debtors turnover ratio, which stands at 14.79 times. Despite these positive indicators, the stock has consistently underperformed against the China Shanghai Composite over the last three years, reflecting a complex financial landscape for investors.